Contact: Dawn Peters sciencenewsroom@wiley.com 781-388-8408 Wiley Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus (HBV) replication. Findings published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggest seasonal fluctuations in vitamin D and HBV levels point…
Contact: Jennifer Beal sciencenewsroom@wiley.com 44-012-437-70633 Wiley People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are likely to experience a variety of adverse effects, according to an updated…
Contact: Dawn Peters medicalnews@wiley.com 781-388-8408 Wiley-Blackwell Study finds caffeine in sources other than coffee does not have similar effect Researchers from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) determined that patients with chronic hepatitis C virus (HCV) who consumed more than 308 mg of caffeine daily had milder liver fibrosis. The…
Contact: Kim Irwin kirwin@mednet.ucla.edu 310-206-2805 University of California – Los Angeles Health Sciences Natural compound blocks hepatitis C infection Finding may lead to a new treatment Researchers have identified two cellular proteins that are important factors in hepatitis C virus infection, a finding that may result in the approval of new and less toxic treatments…
Public release date: 25-Sep-2008 Re-Posted for Filing Contact: Rachel Seroka rseroka@aan.com 651-695-2738 American Academy of Neurology Majority of children vaccinated against hepatitis B not at increased risk of MS ST. PAUL, Minn. – The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS), according to a…
Finding may lead to a new treatment Researchers have identified two cellular proteins that are important factors in hepatitis C virus infection, a finding that may result in the approval of new and less toxic treatments for the disease, which can lead to liver cancer and cirrhosis. An estimated 270 to 300 million people worldwide…
Contact: Sue McGreevey smcgreevey@partners.org 617-724-2764 Massachusetts General Hospital MGH study reveals mechanism key to maintaining chronic infection, potential therapy target A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic infection. A team…
Interferon does not slow or halt the progression of chronic hepatitis C and advanced liver disease in patients who haven’t responded to previous attempts to eradicate the disease, a national study in which the Saint Louis University School of Medicine participated has found. Patients in the trial who were treated with interferon…
Contact: Lixin Zhu wjg@wjgnet.com 86-108-538-1892 World Journal of Gastroenterology Who will recover spontaneously from hepatitis C virus infection More than 3% of world population is infected with hepatitis C virus (HCV). The outcome of HCV infections is either self recovery or chronic hepatitis, and many of the chronic infections will develop into liver cirrhosis or…
